Dulaglutide (Trulicity, GLP-1 receptor agonist)-Therapeutic peptides (hIgG4 Fc fusion) drug benchmark for in-vivo/in-vitro study

Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

Order information

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-peptide-002-1mg	1mg	3090
GMP-Bios-peptide-002-10mg	10mg	21890
GMP-Bios-peptide-002-100mg	100mg	148000
GMP-Bios-peptide-002-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Product Name	Dulaglutide
Brand name	Trulicity
CAS No.	923950-08-7
Resource (expression host)	mammalian
Specics/Isotypes	Recombinant protein fused to an Fc fragment of human IgG4
Biological Activity	Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4.
Tag	His
Purity	Purity: ≥95% (SDS-PAGE)
Application	Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.
Predicted Molecular Mass	3213.2
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.